ENTACorporate•businesswire•
Enanta Pharmaceuticals to Participate in the H.C. Wainwright & Co. “HCW@Home” Series
Sentiment:Negative (15)
Summary
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in a virtual fireside chat on Tuesday, August 12, 2025 at 1:00 p.m. ET as part of the H.C. Wainwright & Co. “HCW@Home” series. A live webcast of the event will be accessible by visiting the “Events and Presentations” section
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 5, 2025 by businesswire